Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Ardent phase 2b clinical trial of IMR-687 : Imara wraps up patient enrollment Imara Inc. said that it has wrapped up enrollment of patients in the Ardent phase 2b clinical trial… bySrinathAugust 8, 2021